MENU
+Compare
AMRX
Stock ticker: NASDAQ
AS OF
Jul 25 closing price
Price
$8.06
Change
+$0.06 (+0.75%)
Capitalization
1.87B

AMRX Amneal Pharmaceuticals Forecast, Technical & Fundamental Analysis

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U... Show more

AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for AMRX with price predictions
Jul 25, 2025

AMRX's RSI Indicator peaks and leaves overbought zone

The 10-day RSI Indicator for AMRX moved out of overbought territory on July 08, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 instances where the indicator moved out of the overbought zone. In of the 32 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 17, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on AMRX as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for AMRX turned negative on July 15, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 65 cases where AMRX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AMRX advanced for three days, in of 274 cases, the price rose further within the following month. The odds of a continued upward trend are .

AMRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 194 cases where AMRX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. AMRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (94.340) is normal, around the industry mean (62.701). P/E Ratio (90.000) is within average values for comparable stocks, (88.783). AMRX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.913). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (0.445) is also within normal values, averaging (18.372).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

AMRX is expected to report earnings to fall 19.05% to 17 cents per share on August 05

Amneal Pharmaceuticals AMRX Stock Earnings Reports
Q2'25
Est.
$0.17
Q1'25
Beat
by $0.06
Q4'24
Missed
by $0.03
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.02
The last earnings report on May 02 showed earnings per share of 20 cents, beating the estimate of 15 cents. With 1.12M shares outstanding, the current market capitalization sits at 1.87B.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
400 Crossing Boulevard
Phone
+1 908 947-3120
Employees
7700
Web
https://www.amneal.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DREVX20.230.13
+0.65%
BNY Mellon Large Cap Securities Inc
SMCIX21.340.12
+0.57%
Shelton S&P Smallcap Index Investor
IEDZX13.960.07
+0.50%
Voya Large Cap Value R6
VRTIX347.261.38
+0.40%
Vanguard Russell 2000 Index I
GCPAX20.650.04
+0.19%
Gateway Equity Call Premium A

AMRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with PAHC. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
+0.75%
PAHC - AMRX
47%
Loosely correlated
-0.88%
VTRS - AMRX
45%
Loosely correlated
+0.64%
AMPH - AMRX
40%
Loosely correlated
-1.15%
EBS - AMRX
39%
Loosely correlated
-4.02%
ZTS - AMRX
39%
Loosely correlated
-0.46%
More